{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T16:32:25Z","timestamp":1758040345931,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation, China","doi-asserted-by":"publisher","award":["81573259"],"award-info":[{"award-number":["81573259"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.amjcard.2019.05.058","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T11:04:24Z","timestamp":1559905464000},"page":"702-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status"],"prefix":"10.1016","volume":"124","author":[{"given":"Xiaojuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yachao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengling","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzhong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2019.05.058_bib0001","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 esc\/eas guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0002","doi-asserted-by":"crossref","unstructured":"Third report of the national cholesterol education program (ncep) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel iii) final report. Circulation. 2002;106:3143\u20133421","DOI":"10.1161\/circ.106.25.3143"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0003","first-page":"1263","article-title":"2016 canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0004","doi-asserted-by":"crossref","first-page":"e1144","DOI":"10.1161\/CIR.0000000000000626","article-title":"Systematic review for the 2018 aha\/acc\/aacvpr\/aapa\/abc\/acpm\/ada\/ags\/apha\/aspc\/nla\/pcna guideline on the management of blood cholesterol","volume":"139","author":"Wilson","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3132\/dvdr.2008.046","article-title":"The residual risk reduction initiative: A call to action to reduce residual vascular risk in dyslipidaemic patient","volume":"5","author":"Fruchart","year":"2008","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","article-title":"Residual cardiovascular risk despite optimal ldl cholesterol reduction with statins: The evidence, etiology, and therapeutic challenges","volume":"14","author":"Sampson","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0007","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1475-2840-13-26","article-title":"Residual macrovascular risk in 2013: what have we learned?","volume":"13","author":"Fruchart","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0008","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2012.03.127","article-title":"How to control residual cardiovascular risk despite statin treatment: focusing on hdl-cholesterol","volume":"166","author":"Lim","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0009","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"Arsenault","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.amjcard.2015.06.040","article-title":"Usefulness of low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease in chinese","volume":"116","author":"Gu","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0011","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.atherosclerosis.2007.07.033","article-title":"High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review","volume":"196","author":"Amarenco","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0012","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.atherosclerosis.2010.02.020","article-title":"Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in chinese: the results of a 15-year chinese multi-provincial cohort study (cmcs)","volume":"211","author":"Ren","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijcard.2009.03.123","article-title":"Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the epic-norfolk prospective population study","volume":"143","author":"Rana","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0014","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2337\/dc16-1958","article-title":"Triglyceride and hdl-c dyslipidemia and risks of coronary heart disease and ischemic stroke by glycemic dysregulation status: the strong heart study","volume":"40","author":"Lee","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007607","article-title":"Trajectories of long-term normal fasting plasma glucose and risk of coronary heart disease: A prospective cohort study","volume":"7","author":"Yuan","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/jch.13441","article-title":"The associations of lipids and lipid ratios with stroke: a prospective cohort study","volume":"21","author":"Liu","year":"2019","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2105\/AJPH.88.1.15","article-title":"Use and misuse of population attributable fractions","volume":"88","author":"Rockhill","year":"1998","journal-title":"Am J Public Health"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2014.08.007","article-title":"Long-term risk of cardiovascular events across a spectrum of adverse major plasma lipid combinations in the framingham heart study","volume":"168","author":"Andersson","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of ldl cholesterol, non-hdl cholesterol, and apolipoprotein b levels with risk of cardiovascular events among patients treated with statins: a meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0021","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1161\/CIRCULATIONAHA.107.713438","article-title":"Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment","volume":"117","author":"Kastelein","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0022","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.amjcard.2010.05.002","article-title":"Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control","volume":"106","author":"Carey","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0023","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/ATVBAHA.110.219055","article-title":"Insulin resistance and the relationship of a dyslipidemia to coronary heart disease: the framingham heart study","volume":"31","author":"Robins","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0024","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1093\/eurheartj\/suw009","article-title":"Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0025","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.amjcard.2015.08.039","article-title":"Metabolic dyslipidemia and risk of coronary heart disease in 28,318 adults with diabetes mellitus and low-density lipoprotein cholesterol <100 mg\/dl","volume":"116","author":"Rana","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0026","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-015-3525-8","article-title":"Pathophysiology of diabetic dyslipidaemia: Where are we?","volume":"58","author":"Verges","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0027","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/MOL.0000000000000318","article-title":"Diabetic dyslipidaemia","volume":"27","author":"Soran","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0028","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/ATVBAHA.111.241463","article-title":"Selective hepatic insulin resistance, vldl overproduction, and hypertriglyceridemia","volume":"32","author":"Sparks","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0029","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMsb022365","article-title":"Understanding the divergent data on postmenopausal hormone therapy","volume":"348","author":"Grodstein","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/pr.107.08002","article-title":"Vascular actions of estrogens: Functional implications","volume":"60","author":"Miller","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0031","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1067\/mhj.2001.109946","article-title":"Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis","volume":"141","author":"Burke","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0032","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11886-006-0104-0","article-title":"Sex differences in lipoprotein metabolism and dietary response: Basis in hormonal differences and implications for cardiovascular disease","volume":"8","author":"Knopp","year":"2006","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0033","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/2047487313516563","article-title":"Lifetime risk for cardiovascular disease in a chinese population: the Chinese multi-provincial cohort study","volume":"22","author":"Wang","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0034","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","article-title":"Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women","volume":"298","author":"Bansal","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2019.05.058_bib0036","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2014.05.916","article-title":"Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in china: Results of the dyslipidemia international study (dysis)","volume":"235","author":"Zhao","year":"2014","journal-title":"Atherosclerosis"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919306381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914919306381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:30:54Z","timestamp":1757572254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914919306381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0002914919306381"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.058","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Disease Risk Across a Spectrum of Adverse Plasma Lipid Combinations by Gender and Glycemic Status","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2019.05.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}